Assessing breast reconstructive care in B.C.
The purpose of this provincial assessment is to measure the quality metrics of the delivery of breast cancer care across B.C.
Status
Recruiting
Recruiting
Comparing surgical and nonsurgical chronic lymphedema treatment after breast cancer therapy
The purpose of this study is to determine whether lymphatic surgery provides better quality of life compared to only conservative therapy for patients with breast cancer-related lymphedema.
Status
Recruiting
Closed for Recruitment
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Primary Breast Cancer
This two-arm, randomized, open-label, multicenter study will evaluate the efficacy and safety of Kadcyla (trastuzumab emtansine, also known as T-DM1) in combination with Perjeta (pertuzumab) versus Herceptin (trastuzumab) in combination with Perjeta and a taxane as adjuvant therapy in patients with HER2-positive primary invasive breast cancer.
Status
Closed for Recruitment